Chinese drug discovery startup Meta Pharmaceuticals has raised a combined $15 million from its seed and Series pre-A rounds of financing to develop innovative therapeutics for patients suffering from autoimmune diseases.
Continue reading with Data Vantage
Venture-backed company data in SE Asia, India, Pakistan, Bangladesh.
Instant investment updates and valuations.
Tailored search, 3 monthly reports.
Industry-trusted platform.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
